SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?


To: Anthony Wong who wrote (473)7/7/1998 2:31:00 PM
From: Anthony Wong  Read Replies (1) | Respond to of 1722
 
British doctors call for orderly roll out of Viagra
yahoo.co.uk



To: Anthony Wong who wrote (473)7/7/1998 3:41:00 PM
From: johnny cooley  Read Replies (1) | Respond to of 1722
 
Lipitor has captured 35% of the market and continues to grab
more market share from competitor zocor this is significant
since zocor brings in around 30% of Merck's baseline profits
My daughter is currently being treated with a prescribed
acne medicine which has increased her cholesterol she was
prescribed lipitor . Talking to the physician it became
apparent it was his drug of choice.Whether wla markets
lipitor better or the results are that much better I can not
give an opinion . I do feel confident that regardless
what drugs are currently in the pipeline, lipitor alone can
carry this stock a long way . Wla also trends with
the market if we see a correction wla will follow , I think
we are in the middle of a strong summer rally which should
push wla over 100 by October . Watch for earnings and a lot
of institutional buying to carry wla forward.
My investment in wla are Jan 70 calls which I was fortunate
to purchase @ $4 a couple of weeks ago I will let my
3 bagger continue to run ------- See all positives